Global Anti-Venom Market Report History And Forecast 2015-2026
Summary
Market Analysis and Insights: Global Anti-Venom Market
The global Anti-Venom market was valued at US$ 891.14 million in 2019 and it is expected to reach US$ 1179.43 million by the end of 2026, growing at a CAGR of 4.17% during 2020-2026.
Global Anti-Venom Scope and Market Size
The global Anti-Venom market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Venom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Segment by Type
Polyvalent Anti-Venom
Monovalent Anti-Venom
Segment by Application
Non-profit Institutions
Hospitals and Clinics
By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
South Korea
India
Southeast Asia
Australia
Europe
Spain
Denmark
Italy
France
Latin America
Brazil
Argentina
Middle East & Africa
Middle East
Africa
- 1 ANTI-VENOM MARKET OVERVIEW
- 1.1 Anti-Venom Product Overview
- 1.2 Anti-Venom Market Segment by Type
- 1.2.1 Polyvalent Anti-Venom
- 1.2.2 Monovalent Anti-Venom
- 1.3 Global Anti-Venom Market Size by Type (2015-2026)
- 1.3.1 Global Anti-Venom Market Size Overview by Type (2015-2026)
- 1.3.2 Global Anti-Venom Historic Market Size Review by Type (2015-2020)
- 1.3.2.1 Global Anti-Venom Sales Market Share Breakdown by Type (2015-2020)
- 1.3.2.2 Global Anti-Venom Revenue Market Share Breakdown by Type (2015-2020)
- 1.3.2.3 Global Anti-Venom Average Selling Price (ASP) by Type (2015-2020)
- 1.3.3 Global Anti-Venom Market Size Forecast by Type (2021-2026)
- 2 VENOMOUS SNAKEBITES BY REGION
- 3 GLOBAL ANTI-VENOM MARKET COMPETITION BY COMPANY
- 3.1 Global Top Players by Anti-Venom Sales (2018-2020)
- 3.2 Global Top Players by Anti-Venom Revenue (2018-2020)
- 3.3 Global Top Players by Anti-Venom Average Selling Price (ASP) & (2018-2020)
- 3.4 Anti-Venom Market Competitive Situation and Trends
- 3.4.1 Anti-Venom Market Concentration Rate (2018-2020)
- 3.4.2 Global 5 and 10 Largest Manufacturers by Anti-Venom Sales and Revenue in 2019
- 3.5 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Venom as of 2019)
- 3.6 Manufacturing Base Distribution of Key Manufacturers Anti-Venom Market
- 3.7 Key Manufacturers Anti-Venom Product Offered
- 3.8 Mergers & Acquisitions, Expansion
- 4 GLOBAL ANTI-VENOM BY REGION
- 4.1 Global Anti-Venom Market Size and CAGR by Region: 2015 VS 2020 VS 2026
- 4.2 Global Anti-Venom Market Size Market Share by Region (2015-2020)
- 4.2.1 Global Anti-Venom Sales Market Share by Region (2015-2020)
- 4.2.2 Global Anti-Venom Revenue Market Share by Region (2015-2020)
- 4.2.3 Global Anti-Venom Sales, Revenue, Price and Gross Margin (2015-2020)
- 4.3 Global Anti-Venom Market Size Market Share by Region (2021-2026)
- 4.3.1 Global Anti-Venom Sales Market Share by Region (2021-2026)
- 4.3.2 Global Anti-Venom Revenue Market Share by Region (2021-2026)
- 4.3.3 Global Anti-Venom Sales, Revenue, Price and Gross Margin (2021-2026)
- 5 GLOBAL ANTI-VENOM BY APPLICATION
- 5.1 Anti-Venom Segment by Application
- 5.1.1 Non-profit Institutions
- 5.1.2 Hospitals and Clinics
- 5.2 Global Anti-Venom Sales by Application: 2015 VS 2020 VS 2026
- 5.3 Global Anti-Venom Historic Sales by Application (2015-2020)
- 5.4 Global Anti-Venom Forecasted Sales by Application (2021-2026)
- 6 NORTH AMERICA ANTI-VENOM MARKET SIZE BY COUNTRY
- 6.1.1 North America Anti-Venom Sales Market Share by Country (2015-2020)
- 6.1.2 North America Anti-Venom Revenue Market Share by Country (2015-2020)
- 7 EUROPE ANTI-VENOM MARKET SIZE BY COUNTRY
- 7.1.1 Europe Anti-Venom Sales Market Share by Country (2015-2020)
- 7.1.2 Europe Anti-Venom Revenue Market Share by Country (2015-2020)
- 8 ASIA-PACIFIC ANTI-VENOM MARKET SIZE BY REGION
- 8.1.1 Asia-Pacific Anti-Venom Sales Market Share by Region (2015-2020)
- 8.1.2 Asia-Pacific Anti-Venom Revenue Market Share by Region (2015-2020)
- 9 LATIN AMERICA ANTI-VENOM MARKET SIZE BY COUNTRY
- 9.1.1 Latin America Anti-Venom Sales Market Share by Country (2015-2020)
- 9.1.2 Latin America Anti-Venom Revenue Market Share by Country (2015-2020)
- 10 MIDDLE EAST AND AFRICA ANTI-VENOM MARKET SIZE BY COUNTRY
- 10.1.1 Middle East and Africa Anti-Venom Sales Market Share by Country (2015-2020)
- 10.1.2 Middle East and Africa Anti-Venom Revenue Market Share by Country (2015-2020)
- 11 COMPANY PROFILES AND KEY FIGURES IN ANTI-VENOM BUSINESS
- 11.1 CSL
- 11.1.1 CSL Corporation Information
- 11.1.2 CSL Business Overview
- 11.1.3 CSL Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.1.4 CSL Anti-Venom Products Offered
- 11.2 Merck
- 11.2.1 Merck Corporation Information
- 11.2.2 Merck Business Overview
- 11.2.3 Merck Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.2.4 Merck Anti-Venom Products Offered
- 11.3 BTG
- 11.3.1 BTG Corporation Information
- 11.3.2 BTG Business Overview
- 11.3.3 BTG Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.3.4 BTG Anti-Venom Products Offered
- 11.4 Pfizer
- 11.4.1 Pfizer Corporation Information
- 11.4.2 Pfizer Business Overview
- 11.4.3 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.4.4 Pfizer Anti-Venom Products Offered
- 11.5 Haffkine Bio-Pharmaceutical
- 11.5.1 Bharat Serums and Vaccines Information
- 11.5.2 Haffkine Bio-Pharmaceutical Business Overview
- 11.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Products Offered
- 11.6 Rare Disease Therapeutics
- 11.6.1 Rare Disease Therapeutics Corporation Information
- 11.6.2 Rare Disease Therapeutics Business Overview
- 11.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.6.4 Rare Disease Therapeutics Anti-Venom Products Offered
- 11.7 Flynn Pharma
- 11.7.1 Flynn Pharma Corporation Information
- 11.7.2 Flynn Pharma Business Overview
- 11.7.3 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.7.4 Flynn Pharma Anti-Venom Products Offered
- 11.8 Vins Bioproducts
- 11.8.1 Vins Bioproducts Corporation Information
- 11.8.2 Vins Bioproducts Business Overview
- 11.8.3 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.8.4 Vins Bioproducts Anti-Venom Products Offered
- 11.9 Bharat Serums and Vaccines
- 11.9.1 Bharat Serums and Vaccines Corporation Information
- 11.9.2 Bharat Serums and Vaccines Business Overview
- 11.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.9.4 Bharat Serums and Vaccines Anti-Venom Products Offered
- 11.10 Serum Biotech
- 11.10.1 Serum Biotech Corporation Information
- 11.10.2 Serum Biotech Business Overview
- 11.10.3 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.10.4 Serum Biotech Anti-Venom Products Offered
- 11.11 Micropaharm Limited
- 11.11.1 Micropaharm Limited Corporation Information
- 11.11.2 Micropaharm Limited Business Overview
- 11.11.3 Micropaharm Limited Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
- 11.11.4 Micropaharm Limited Anti-Venom Products Offered
- 12 ANTI-VENOM UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
- 12.1 Anti-Venom Key Raw Materials
- 12.1.1 Key Raw Materials
- 12.1.2 Raw Materials Key Suppliers
- 12.2 Manufacturing Cost Structure
- 12.2.1 Raw Materials
- 12.2.2 Labor Cost
- 12.2.3 Manufacturing Expenses
- 12.3 Anti-Venom Industrial Chain Analysis
- 12.4 Market Opportunities, Challenges, Risks, and Influences Factors Analysis
- 12.4.1 Anti-Venom Market Opportunities and Drivers
- 12.4.2 Anti-Venom Market Challenges
- 12.4.3 Porter’s Five Forces Analysis
- 13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
- 13.1 Sales Channel
- 13.2 Distributors
- 13.3 Downstream Customers
- 14 RESEARCH FINDINGS AND CONCLUSION
- 15 APPENDIX
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.2 Author Details
- 15.3 Disclaimer
- List of Tables and Figures
- Table 1. Global Anti-Venom Market Size Growth Potential by Type: CAGR (2020-2026) & (K Vials)
- Table 2. Global Anti-Venom Sales by Type (2015-2020) & (K Vials)
- Table 3. Global Anti-Venom Sales Share by Type (2015-2020)
- Table 4. Global Anti-Venom Revenue (US$ Million) by Type (2015-2020)
- Table 5. Global Anti-Venom Revenue Share by Type (2015-2020)
- Table 6. Global Anti-Venom Average Selling Price (ASP) & (USD/Vial) by Type (2015-2020)
- Table 7. Global Anti-Venom Sales by Type (2021-2026) & (K Vials)
- Table 8. Global Anti-Venom Sales Share by Type (2021-2026)
- Table 9. Global Venomous Snakebites Comparison by Region in 2019 (in thousands)
- Table 10. Global Anti-Venom Sales (K Vials) by Company (2018-2020)
- Table 11. Global Anti-Venom Sales Share by Company (2018-2020)
- Table 12. Global Anti-Venom Revenue (US$ Million) by Company (2018-2020)
- Table 13. Global Anti-Venom Revenue Share by Company (2018-2020)
- Table 14. Global Market Anti-Venom Average Selling Price (ASP) & (USD/Vial) by Company (2018-2020)
- Table 15. Global Anti-Venom Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Venom as of 2019)
- Table 17. Date of Key Manufacturers Enter into Anti-Venom Market
- Table 18. Key Manufacturers Anti-Venom Product Type
- Table 19. Mergers & Acquisitions, Expansion Plans
- Table 20. Global Anti-Venom Market Size Comparison by Region (2015-2026) & (US$ Million): 2015 VS 2020 VS 2026
- Table 21. Global Anti-Venom Sales (K Vials) by Region (2015-2020)
- Table 22. Global Anti-Venom Sales Market Share by Region (2015-2020)
- Table 23. Global Anti-Venom Revenue (US$ Million) by Region (2015-2020)
- Table 24. Global Anti-Venom Revenue Market Share by Region (2015-2020)
- Table 25. Global Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)
- Table 26. Global Anti-Venom Sales (K Vials) by Region (2021-2026)
- Table 27. Global Anti-Venom Sales Market Share by Region (2021-2026)
- Table 28. Global Anti-Venom Revenue (US$ Million) by Region (2021-2026)
- Table 29. Global Anti-Venom Revenue Market Share by Region (2021-2026)
- Table 30. Global Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026)
- Table 31. Global Anti-Venom Sales (K Vials) by Application: 2015 VS 2020 VS 2026
- Table 32. Global Anti-Venom Sales (K Vials) by Application (2015-2020)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook